Bleeding risk in patients with autosomal dominant polycystic kidney disease treated with acetylsalicylic acid: implications for prevention of preeclampsia

M. F.C. de Jong*, H. M. Komdeur, M. Salih, E. Meijer, The DIPAK consortium

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)2425-2427
Number of pages3
JournalJournal of Nephrology
Volume35
Issue number9
Early online date13 Jul 2022
DOIs
Publication statusPublished - Dec 2022

Bibliographical note

Funding Information:
The DIPAK Consortium is sponsored by the Dutch Kidney Foundation (Grants CP10.12 and CP15.01) and the Ministry of Economic Affairs by means of the PPP Allowance made available by the Top Sector Life Sciences & Health to stimulate public–private partnerships (TKI LSHM 15018).

Cite this